p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers
暂无分享,去创建一个
G. Montgomery | B. Leggett | V. Whitehall | K. Mallitt | S. Greco | R. Buttenshaw | C. Bond | I. Ramsnes | A. Umapathy | Zhen Zhen Zhao
[1] V. Lemmens,et al. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] M. Tzardi,et al. BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome , 2010, British Journal of Cancer.
[3] R. Malekzadeh,et al. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K‐ras mutations , 2008, Journal of cellular physiology.
[4] S. Kakar,et al. Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability. , 2008, Archives of pathology & laboratory medicine.
[5] D. Sargent,et al. Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer , 2008, Clinical Cancer Research.
[6] M. Kloor,et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.
[7] S. Fox,et al. High resolution melting for mutation scanning of TP53 exons 5–8 , 2007, BMC Cancer.
[8] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[9] Emily J. Greenspan,et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. , 2007, Cancer Research.
[10] N. Martin,et al. KRAS variation and risk of endometriosis. , 2006, Molecular human reproduction.
[11] Rozemary Karamatic,et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. , 2006, Gastroenterology.
[12] D. Calistri,et al. KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[13] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[14] S. Kakar,et al. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non‐mucinous colorectal cancer , 2006, International journal of cancer.
[15] Ying Liu,et al. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] Christian B. Woods,et al. Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.
[17] D. Kerr,et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Amadori,et al. Mutation analysis of p53, K‐ras, and BRAF genes in colorectal cancer progression , 2005, Journal of cellular physiology.
[19] R. Wolff,et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. , 2005, Cancer research.
[20] J. Hopper,et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[21] R. Houlston,et al. Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Matsubara,et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.
[23] Y. Hatakeyama,et al. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas. , 2004, Anticancer research.
[24] B. Iacopetta. TP53 mutation in colorectal cancer , 2003, Human mutation.
[25] K. Kinzler,et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status , 2002, Nature.
[26] J. Coxhead,et al. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Leppert,et al. Prognostic significance of p53 mutations in colon cancer at the population level , 2002, International journal of cancer.
[28] C. Peyssonnaux,et al. The Raf/MEK/ERK pathway: new concepts of activation , 2001, Biology of the cell.
[29] M. Leppert,et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] J. Herman,et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. , 2001, Cancer research.
[31] B. Leggett,et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. , 2001, Cancer research.
[32] B. Iacopetta,et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. , 2000, European journal of cancer.
[33] B. Leggett,et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer , 2000, The British journal of surgery.
[34] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.
[35] N. Ahuja,et al. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] C Caldas,et al. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis , 1999, British Journal of Cancer.
[37] B. Leggett,et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. , 1999, Journal of clinical pathology.
[38] S. Baylin,et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. , 1999, Cancer research.
[39] B. Leggett,et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? , 1999, Journal of clinical pathology.
[40] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[41] K. Do,et al. Morphology of sporadic colorectal cancer with DNA replication errors , 1998, Gut.
[42] R. Parsons,et al. p53 alterations are associated with improved prognosis in distal colonic carcinomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] M. Loda,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.
[44] D. Lane,et al. p53 In tumour pathology: Can we trust immunohistochemistry?—revisited! , 1994, The Journal of pathology.
[45] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[46] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[47] A. Børresen-Dale,et al. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.